-
1
-
-
84983671799
-
The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013
-
1 Stanaway, JD, Flaxman, AD, Naghavi, M, et al. The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013. Lancet 388 (2016), 1081–1088.
-
(2016)
Lancet
, vol.388
, pp. 1081-1088
-
-
Stanaway, J.D.1
Flaxman, A.D.2
Naghavi, M.3
-
2
-
-
84963894597
-
Systematic review: current concepts and challenges for the direct-acting antiviral era in hepatitis C cirrhosis
-
2 Majumdar, A, Kitson, MT, Roberts, SK, Systematic review: current concepts and challenges for the direct-acting antiviral era in hepatitis C cirrhosis. Alilment Pharmacol Ther 46 (2016), 1276–1292.
-
(2016)
Alilment Pharmacol Ther
, vol.46
, pp. 1276-1292
-
-
Majumdar, A.1
Kitson, M.T.2
Roberts, S.K.3
-
3
-
-
84990303165
-
Liver disease burden of hepatitis C virus infection in Iran and the potential impact of various treatment strategies on the disease burden
-
3 Hajarizadeh, B, Razavi-Shearer, D, Merat, S, Alavian, S, Malekzadeh, R, Razavi, AH, Liver disease burden of hepatitis C virus infection in Iran and the potential impact of various treatment strategies on the disease burden. Hepat Mon, 16, 2016, e37234.
-
(2016)
Hepat Mon
, vol.16
, pp. e37234
-
-
Hajarizadeh, B.1
Razavi-Shearer, D.2
Merat, S.3
Alavian, S.4
Malekzadeh, R.5
Razavi, A.H.6
-
4
-
-
84892921817
-
Acute hepatitis C: management in the rapidly evolving world of HCV
-
4 Sharma, SA, Feld, JJ, Acute hepatitis C: management in the rapidly evolving world of HCV. Curr Gastroenterol Rep, 16, 2014, 371.
-
(2014)
Curr Gastroenterol Rep
, vol.16
, pp. 371
-
-
Sharma, S.A.1
Feld, J.J.2
-
5
-
-
84921060015
-
Global distribution and prevalence of hepatitis C virus genotypes
-
5 Messina, JP, Humphreys, I, Flaxman, A, et al. Global distribution and prevalence of hepatitis C virus genotypes. Hepatology 61 (2015), 77–87.
-
(2015)
Hepatology
, vol.61
, pp. 77-87
-
-
Messina, J.P.1
Humphreys, I.2
Flaxman, A.3
-
6
-
-
84924348161
-
Hepatitis C therapy: Looking toward interferon-sparing regimens
-
6 Au, TH, Destache, CJ, Vivekanandan, R, Hepatitis C therapy: Looking toward interferon-sparing regimens. J Am Pharm Assoc 55 (2015), e72–e84.
-
(2015)
J Am Pharm Assoc
, vol.55
, pp. e72-e84
-
-
Au, T.H.1
Destache, C.J.2
Vivekanandan, R.3
-
7
-
-
84920279600
-
Strategies to manage hepatitis C virus (HCV) infection disease burden—volume 2
-
7 Gane, E, Kershenobich, D, Seguin-Devaux, C, et al. Strategies to manage hepatitis C virus (HCV) infection disease burden—volume 2. J Viral Hepat 22 (2015), 46–73.
-
(2015)
J Viral Hepat
, vol.22
, pp. 46-73
-
-
Gane, E.1
Kershenobich, D.2
Seguin-Devaux, C.3
-
8
-
-
84973369512
-
Hepatitis C disease burden in the United States in the era of oral direct-acting antivirals
-
8 Chhatwal, J, Wang, X, Ayer, T, et al. Hepatitis C disease burden in the United States in the era of oral direct-acting antivirals. Hepatology 64 (2016), 1442–1450.
-
(2016)
Hepatology
, vol.64
, pp. 1442-1450
-
-
Chhatwal, J.1
Wang, X.2
Ayer, T.3
-
9
-
-
84928215228
-
Ledipasvir/sofosbuvir regimens for chronic hepatitis C infection: insights from a work productivity economic model from the United States
-
9 Younossi, ZM, Jiang, Y, Smith, NJ, Stepanova, M, Beckerman, R, Ledipasvir/sofosbuvir regimens for chronic hepatitis C infection: insights from a work productivity economic model from the United States. Hepatology 61 (2015), 1471–1478.
-
(2015)
Hepatology
, vol.61
, pp. 1471-1478
-
-
Younossi, Z.M.1
Jiang, Y.2
Smith, N.J.3
Stepanova, M.4
Beckerman, R.5
-
10
-
-
84957440472
-
Impact of eradicating hepatitis C virus on the work productivity of chronic hepatitis C (CH-C) patients: an economic model from five European countries
-
10 Younossi, Z, Brown, A, Buti, M, et al. Impact of eradicating hepatitis C virus on the work productivity of chronic hepatitis C (CH-C) patients: an economic model from five European countries. J Viral Hep 23 (2015), 217–226.
-
(2015)
J Viral Hep
, vol.23
, pp. 217-226
-
-
Younossi, Z.1
Brown, A.2
Buti, M.3
-
11
-
-
84978709118
-
Association of work productivity with clinical and patient-reported factors in patients infected with hepatitis C virus
-
11 Younossi, ZM, Stepanova, M, Henry, L, et al. Association of work productivity with clinical and patient-reported factors in patients infected with hepatitis C virus. J Viral Hep 23 (2016), 623–630.
-
(2016)
J Viral Hep
, vol.23
, pp. 623-630
-
-
Younossi, Z.M.1
Stepanova, M.2
Henry, L.3
-
12
-
-
84964621673
-
Extrahepatic manifestations of hepatitis C: a meta-analysis of prevalence, quality of life, and economic burden
-
12 Younossi, Z, Park, H, Henry, L, Adeyemi, A, Stepanova, M, Extrahepatic manifestations of hepatitis C: a meta-analysis of prevalence, quality of life, and economic burden. Gastroenterology 150 (2016), 1599–1608.
-
(2016)
Gastroenterology
, vol.150
, pp. 1599-1608
-
-
Younossi, Z.1
Park, H.2
Henry, L.3
Adeyemi, A.4
Stepanova, M.5
-
13
-
-
84866898184
-
Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: a community-based long-term prospective study
-
13 Lee, MH, Yang, HI, Lu, SN, et al. Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: a community-based long-term prospective study. J Infect Dis 206 (2012), 469–477.
-
(2012)
J Infect Dis
, vol.206
, pp. 469-477
-
-
Lee, M.H.1
Yang, H.I.2
Lu, S.N.3
-
14
-
-
84945534889
-
Extrahepatic morbidity and mortality of chronic hepatitis C
-
14 Negro, F, Forton, D, Craxi, A, Sulkowsi, MS, Feld, JJ, Manns, MP, Extrahepatic morbidity and mortality of chronic hepatitis C. Gastroenterology 149 (2015), 1345–1360.
-
(2015)
Gastroenterology
, vol.149
, pp. 1345-1360
-
-
Negro, F.1
Forton, D.2
Craxi, A.3
Sulkowsi, M.S.4
Feld, J.J.5
Manns, M.P.6
-
15
-
-
85012924335
-
Draft Global Health Sector Strategies Viral Hepatitis 2016–2021
-
(accessed Nov 29, 2016).
-
15 Assembly, WHOS-NWH, Draft Global Health Sector Strategies Viral Hepatitis 2016–2021. http://www.who.int/hepatitis/strategy2016-2021/Draft_global_health_sector_strategy_viral_hepatitis_13nov.pdf, 2016 (accessed Nov 29, 2016).
-
(2016)
-
-
Assembly, W.-N.1
-
17
-
-
84920274258
-
Historical epidemiology of hepatitis C virus (HCV) in select countries—volume 2
-
17 Saraswat, V, Norris, S, de Knegt, RJ, et al. Historical epidemiology of hepatitis C virus (HCV) in select countries—volume 2. J Viral Hepat 22 (2015), 6–25.
-
(2015)
J Viral Hepat
, vol.22
, pp. 6-25
-
-
Saraswat, V.1
Norris, S.2
de Knegt, R.J.3
-
19
-
-
85012878888
-
E-ZaA, ICF International. Egypt Health Issues Survey 2015. Cairo, Egypt and Rockville, MD, USA
-
(accessed Nov 29, 2016).
-
19 Ministry of Health and Population, Egypt. E-ZaA, ICF International. Egypt Health Issues Survey 2015. Cairo, Egypt and Rockville, MD, USA. https://dhsprogram.com/pubs/pdf/FR313/FR313.pdf, 2015 (accessed Nov 29, 2016).
-
(2015)
-
-
-
20
-
-
84914150658
-
Global epidemiology and genotype distribution of the hepatitis C virus infection
-
20 Gower, E, Estes, C, Blach, S, Razavi-Shearer, K, Razavi, H, Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol 61 (2014), S45–S57.
-
(2014)
J Hepatol
, vol.61
, pp. S45-S57
-
-
Gower, E.1
Estes, C.2
Blach, S.3
Razavi-Shearer, K.4
Razavi, H.5
-
21
-
-
59149085501
-
The global burden of hepatitis C
-
21 Lavanchy, D, The global burden of hepatitis C. Liver Int 29 (2009), 74–81.
-
(2009)
Liver Int
, vol.29
, pp. 74-81
-
-
Lavanchy, D.1
-
22
-
-
78751621217
-
Evolving epidemiology of hepatitis C virus
-
22 Lavanchy, D, Evolving epidemiology of hepatitis C virus. Clin Microbiol Infect 17 (2011), 107–115.
-
(2011)
Clin Microbiol Infect
, vol.17
, pp. 107-115
-
-
Lavanchy, D.1
-
23
-
-
84876149257
-
Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence
-
23 Mohd Hanafiah, K, Groeger, J, Flaxman, AD, Wiersma, ST, Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence. Hepatology 57 (2013), 1333–1342.
-
(2013)
Hepatology
, vol.57
, pp. 1333-1342
-
-
Mohd Hanafiah, K.1
Groeger, J.2
Flaxman, A.D.3
Wiersma, S.T.4
-
24
-
-
84902136664
-
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm
-
24 Razavi, H, Waked, I, Sarrazin, C, et al. The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm. J Viral Hepat 21 (2014), 34–59.
-
(2014)
J Viral Hepat
, vol.21
, pp. 34-59
-
-
Razavi, H.1
Waked, I.2
Sarrazin, C.3
-
25
-
-
84945395977
-
The present and future disease burden of hepatitis C virus (HCV) infections with today's treatment paradigm—volume 3
-
25 Sibley, A, Han, KH, Abourached, A, et al. The present and future disease burden of hepatitis C virus (HCV) infections with today's treatment paradigm—volume 3. J Viral Hepat 22 (2015), 21–41.
-
(2015)
J Viral Hepat
, vol.22
, pp. 21-41
-
-
Sibley, A.1
Han, K.H.2
Abourached, A.3
-
26
-
-
84920270905
-
The present and future disease burden of hepatitis C virus (HCV) infections with today's treatment paradigm - volume 2
-
26 Hatzakis, A, Chulanov, V, Gadano, AC, et al. The present and future disease burden of hepatitis C virus (HCV) infections with today's treatment paradigm - volume 2. J Viral Hepat 22 (2015), 26–45.
-
(2015)
J Viral Hepat
, vol.22
, pp. 26-45
-
-
Hatzakis, A.1
Chulanov, V.2
Gadano, A.C.3
-
27
-
-
0001501655
-
Application of a technique for research and development program evaluation
-
27 Malcolm, DG, Roseboom, JH, Clark, CE, Fazar, W, Application of a technique for research and development program evaluation. Oper Res 7 (1959), 646–669.
-
(1959)
Oper Res
, vol.7
, pp. 646-669
-
-
Malcolm, D.G.1
Roseboom, J.H.2
Clark, C.E.3
Fazar, W.4
-
28
-
-
84873209614
-
A sero-epidemiological study on hepatitis C in China
-
28 Chen, YS, Li, L, Cui, FQ, et al. A sero-epidemiological study on hepatitis C in China. Zhonghua liu xing bing xue za zhi 32 (2011), 888–891.
-
(2011)
Zhonghua liu xing bing xue za zhi
, vol.32
, pp. 888-891
-
-
Chen, Y.S.1
Li, L.2
Cui, F.Q.3
-
29
-
-
84975705180
-
Novel population-based study finding higher than reported hepatocellular carcinoma incidence suggests an updated approach is needed
-
29 Hong, TP, Gow, P, Fink, M, et al. Novel population-based study finding higher than reported hepatocellular carcinoma incidence suggests an updated approach is needed. Hepatology 63 (2016), 1205–1212.
-
(2016)
Hepatology
, vol.63
, pp. 1205-1212
-
-
Hong, T.P.1
Gow, P.2
Fink, M.3
-
30
-
-
84994719196
-
The underreporting of hepatocellular carcinoma to the cancer register and a log-linear model to estimate a more correct incidence
-
published online Aug 17.
-
30 Torner, A, Stokkeland, K, Svensson, A, et al. The underreporting of hepatocellular carcinoma to the cancer register and a log-linear model to estimate a more correct incidence. Hepatology, 2016, 10.1002/hep.2877 published online Aug 17.
-
(2016)
Hepatology
-
-
Torner, A.1
Stokkeland, K.2
Svensson, A.3
|